Loving Tan has received an equity investment from Gauge Capital
Middle-market private equity firm Gauge Capital has invested in premium self-tanning brand Loving Tan, forming a strategic partnership and recapitalizing the business.
Founded in 2010 and headquartered in Brisbane, Australia, Loving Tan is a luxury sunless tan brand. The company services the prestige segment of the beauty industry through four key product categories: self-tan mousse, self-tan creams, tan applicators and removal products, and gifts and sets. Loving Tan products are best known for their high-quality solutions with professional grade efficacy and can be found in a variety of high-end beauty retailers as well as online.
Gauge Capital is a leading middle-market private equity firm based in Southlake, Texas. Gauge invests in five sectors: business services, food and consumer, government and industrial services, healthcare and technology.
Oaklins Intrepid in Los Angeles, one of the premier M&A advisors in the beauty, personal care and wellness industry, acted as the exclusive sell-side financial advisor to Loving Tan in this transaction.
Talk to the deal team
Steven Davis
Oaklins Intrepid
Bryce Cutrino
Oaklins Intrepid
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more